American, European and international hypertension guidelines: Time to shake hands?

Christina Antza1, Ioannis Doundoulakis1,2, Stella Stabouli2,3

  • 13rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, Thessaloniki, Greece.

Insights

Major hypertension guidelines differ on treatment initiation, leading to patient misclassification and confusion. These discrepancies impact cardiovascular risk assessment and treatment decisions for many individuals.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Evidence-Based Medicine

Background:

  • Adhering to evidence-based medicine guidelines is crucial for effective hypertension treatment and preventing cardiovascular events.
  • Current hypertension management relies on guidelines from major international societies.

Purpose of the Study:

  • To compare recent hypertension guidelines from the American College of Cardiology/American Heart Association (ACC/AHA), European Society of Cardiology/European Society of Hypertension (ESC/ESH), and International Society of Hypertension (ISH).
  • To identify key discrepancies in guideline recommendations regarding treatment initiation criteria (when, how, and in whom).

Main Methods:

  • Comparative analysis of the latest ACC/AHA, ESC/ESH, and ISH hypertension guidelines.
  • Focus on contrasting recommendations for initiating antihypertensive therapy.

Main Results:

  • Significant disagreements exist among the three guidelines regarding the definition of hypertension, specifically cut-off blood pressure values.
  • Divergent cut-off values can lead to misclassification of patients into different blood pressure phenotypes.
  • Each guideline proposes distinct risk stratification scores for assessing cardiovascular risk in hypertensive patients.

Conclusions:

  • Discrepancies in hypertension guidelines create confusion for both general practitioners and specialists.
  • Poor agreement between guidelines and diagnostic tools may result in a substantial number of patients not receiving appropriate treatment.
  • Harmonization of guidelines is needed to ensure consistent and optimal patient care.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
172
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
289
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
676
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
236
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
294
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
119